A Conference Season’s Greeting
Glad tidings of progress and confidence this (conference) season! But let’s not dismiss the emerging skills challenge as “humbug.”
James Strachan | | Quick Read
It is the holiday season! But many in the industry will be preoccupied with full schedules rather than full stockings, with an abundance of conferences in the weeks leading up to year-end. Over the last few months, I’ve attended various cell and gene therapy talks and roundtable discussions to glean an overview of the current state of the field.
At the Cell and Gene Therapy Manufacturing conference in Twickenham, UK, there were several interesting case studies demonstrating how processes can be effectively scaled out – from late-stage solid tumor clinical trials to lentiviral vectors. Pernille Linnert Jensen from Novo Nordisk also offered an example of how to transition from large molecule (antibodies in this case) to stem cell manufacturing. For Pernille, training and education was crucial to the endeavor.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.